GAIKER is a participant in a project at a multinational level which is financed by the European Union Competitive and Sustainable Growth Project. The project is to develop innovative technology which will have two aspects or stages: firstly the separation and recovery of components capable of being reused and, subsequently, the recycling of materials used in electronic printed circuit boards (from telephones, T.V.’s, and so on). The great quantity of small parts, different components, solder and other materials used in their manufacture, make their recycling and re-use extremely difficult.
The main aim of this important initiative is the substitution of the use of the solder lead used in these circuits, traditionally regarded as dangerous and restricted by current European Directives, by materials less harmful to the environment (alloys of tin, silver and copper). In this way, the risks to the environment and on human health can be substantially minimised.
The economic importance of the recycling of precious metals used in manufacturing processes justifies the important international participation involved in the project. The volume of electronic printed circuit board material thrown away in the year 2000 in Spain alone was about 200,000 tons and, in Europe, this figure will reach 7.4 million tons in 2004.
Edorta Larrauri Teran | BasqueResearch
Emissions from road construction could be halved using today’s technology
18.05.2020 | Schwedischer Forschungsrat - The Swedish Research Council
When every particle counts: IOW develops comprehensive guidelines for microplastic extraction from environmental samples
11.05.2020 | Leibniz-Institut für Ostseeforschung Warnemünde
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
28.05.2020 | Transportation and Logistics
28.05.2020 | Physics and Astronomy
28.05.2020 | Power and Electrical Engineering